Loading provider…
Loading provider…
Neurology Physician in Bloomington, IL
NPI: 1326233271Primary Practice Location
The Center for Outpatient Medicine
2502 East Empire Street, Bloomington, IL
Primary Employer
Christie Clinic, PLLC
christieclinic.com
HQ Phone
Get MD Barry's Phone Numberphone_androidMobile
Get MD Barry's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 329 | 712 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 220 | 220 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 149 | 166 |
| 4 | 82746Folic acid level, serum | 134 | 134 |
| 5 | 95886Needle measurement and recording of electrical activity of muscles of arm or leg complete study | 134 | 200 |
Authors: Learmonth, Yvonne C, Adamson, Brynn C, Balto, Julia M, Chiu, Chung-Yi, Molina-Guzman, Isabel M, Finlayson, Marcia, Riskin, Barry J, Motl, Robert W
Journal: Health Expect
Publication Date: 2017-05-18
Authors: Sandroff, Brian M, Riskin, Barry J, Agiovlasitis, Stamatis, Motl, Robert W
Journal: J Neurol Sci
Publication Date: 2014-02-28
Accuracy of StepWatch™ and ActiGraph accelerometers for measuring steps taken among persons with multiple sclerosis.
Authors: Brian Sandroff, Robert Motl, Lara Pilutti, Yvonne Learmonth, Ipek Ensari, Deirdre Dlugonski, Rachel Klaren, Swathi Balantrapu, Barry Riskin
Publication Date: 2013-09-04
Lead Sponsor: Satsuma Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Placebos, DRUG: Dihydroergotamine
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Galcanezumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Galcanezumab